News and Trends 1 Dec 2015
Rare Diseases: Still a ‘Blue Ocean’ for Biotechs?
We all know the success stories linked to Rare Disease such as Genzyme. But I wanted to get a deeper understanding on what is today considered as Rare disease, who is acting the field and the reasons for so many Biotech companies to dive into the field. Last week was the RARE 2015 congress in […]